The Board of Directors of Novo Nordisk A/S has authorized a buyback plan on January 31, 2024.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
923.8 DKK | +0.52% | -4.68% | +32.07% |
17/07 | Health Care Climbs as J&J Rallies - Health Care Roundup | DJ |
17/07 | European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.07% | 597B | |
+55.35% | 815B | |
-0.10% | 377B | |
+15.47% | 319B | |
+13.10% | 310B | |
+16.11% | 247B | |
+13.97% | 228B | |
+16.54% | 180B | |
+4.31% | 170B | |
+2.68% | 126B |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- Novo Nordisk A/S authorizes a Buyback Plan.